Evaluation of third-line eradication for H. pylori infection in Japa
Phase 4
- Conditions
- The patients after unseccessful 1st and 2nd line eradicationtreatment
- Registration Number
- JPRN-UMIN000007632
- Lead Sponsor
- Japan Gast Study Group
- Brief Summary
The highest eradication rate was 70% in PPI based one-week triple therapy using AMPC and STFX.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
a history of antimicrobials after 2nd-line eradcation a history of PPI use 1 week before entry a history of NSAID or steriod use 1 month before entry a history of gastrointestinal surgery, the severe liver, renal, and cardiopulmonary dysfunctions a history of drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate
- Secondary Outcome Measures
Name Time Method Adverse effect